Parametric Study to Optimize the Cultivation Conditions of Blood–Brain Barrier Models for In Vitro Drug Testing
Background/Objectives: The permeation behavior of new drug candidates for central nervous system (CNS) diseases is a major bottleneck in drug development. Thus, using a meaningful in vitro blood–brain barrier (BBB) model in the preclinical phase to determine cerebral drug bioavailability is crucial. However, due to the...